CJC-1295 No DAC + Ipamorelin

GHRH analog and growth-hormone secretagogue blend

CJC-1295 No DAC + Ipamorelin is a combination of two separately characterized research peptides: CJC-1295 No DAC, classified as a growth-hormone-releasing hormone (GHRH) analog, and Ipamorelin, classified as a selective growth-hormone secretagogue. Each component has been examined independently in the peptide literature. This page provides background on the blend as a laboratory research material and is not medical guidance and not intended for human or animal use.

Classification and structure

The blend contains two distinct molecules that are studied on their own. CJC-1295 No DAC (also called Mod GRF 1-29) is a synthetic GHRH analog based on the GHRH(1-29) sequence. Ipamorelin is a synthetic pentapeptide classified as a growth-hormone secretagogue that acts on a separate receptor family. Combining them in a single research preparation does not, in itself, imply any interaction, and no synergy is claimed here.

Areas of research

In the scientific literature the two components appear across the following research areas.

• GHRH-analog research — CJC-1295 No DAC appears in studies of the GHRH receptor and the somatotropic axis as a laboratory model peptide.
• Secretagogue research — Ipamorelin appears in the literature on growth-hormone secretagogue receptor signaling in preclinical systems.
• Peptide chemistry — Both peptides feature in synthesis, stability, and analytical-characterization studies.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Store lyophilized peptide cold and protected from light per standard peptide handling practice. Every in-stock lot ships with a verifiable third-party certificate of analysis (COA).